Value Bridge — METHODIST DALLAS MEDICAL CENTER
Current $-30M → Target $-18M (+$12.3M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-30.0M
Current EBITDA
$-17.7M
Target EBITDA
+$12.3M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$2.8M
Payer Mix Optimization
$6.7M
Cost to Collect Reduction
$2.2M
Clean Claim Improvement
$1.7M
Volume & Rate Growth
$11.1M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-30M to $-18M. The highest-impact lever is Volume & Rate Growth at $4.4M probability-weighted.
IC talking point: "We see $12M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $135M in equity value creation."